Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion
Go back to Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billionBIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.34 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $216.34 | 52 Week High | $333.65 | |||
Open | $216.34 | 52 Week Low | $223.02 | |||
Day High | $216.34 | P/E | 27.70 | |||
Day Low | $216.34 | EPS | $7.81 | |||
Volume | 78 |